Investing Profile

Jorge Conde

VCInvestor
General Partner at Andreessen Horowitz
a16z.com/author/jorge-conde/Menlo Park, California
Photo of Jorge Conde, General Partner at Andreessen Horowitz
Your Intro Paths to Jorge Conde

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Jorge is a member of
NewCo Network
1599 CONNECTIONS
University of Washington Applied Physics Laboratory Network
841 CONNECTIONS
Harvard Business School Network
624 CONNECTIONS
Self-Employed Network
495 CONNECTIONS
Morgan Stanley Network
452 CONNECTIONS

Find Jorge Conde on

cb
Current Investing Position
Andreessen Horowitz General Partner
Investment Range
$1M - $100.0M
Sweet Spot
$10.0M
Investments On Record
20
Current Fund Size
$2.2B

Jorge Conde is on these Sector & Stage Rankings

Jorge Conde's Investments On Record (15)

CompanyStageDateRound SizeTotal Raised
Third Arc Bio
Series AFeb 2026$52M
$220M
Co-investors: Arjun Goyal (Vida Ventures)
Phylo
SeedFeb 2026$14M
$14M
Tome Biosciences
Series ADec 2023$210M
$210M
Co-investors: Daniel Lynch (GV (Google Ventures)), Alan Crane (Polaris Partners), Jay Markowitz (ARCH Venture Partners)
Asimov
Series BJan 2023$180M
$180M
Co-investors: Vijay Pande (Andreessen Horowitz), Brad Flora (Y Combinator), Jamie Goldstein (Pillar VC)
Vicinitas Therapeutics
Series AJul 2022$65M
$65M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Cameron Wheeler (Deerfield Management)
CAMP4 Therapeutics
Series BJul 2022$100M
Series AJun 2021$45M
Series AMay 2018$30M
$230M
Co-investors: Andrew Schwab (5am Ventures), Shaan C. Gandhi (Longwood Fund)
Cartography Biosciences
Series AJul 2022$57M
$120M
Co-investors: Michael Baran (Pfizer Venture Investments), David Moskowitz (MPM BioImpact)
Octant Bio
Series BApr 2022$80M
Series AMay 2020$30M
$200M
Co-investors: Katie Haun (Haun Ventures), Lars Fjeldsoe-Nielsen (2xN), Clint Korver (Ulu Ventures), Miriam Rivera (Ulu Ventures), Shawn Dimantha (Angel investor), Stephen Hays (What If Ventures), George C. Petrocheilos (Catalio Capital Management), Sujay Jaswa (WndrCo LLC), Ling Wong (Highbury Group)

Jorge Conde's Experience

Independent Consultant BlueStone Capital Partners, L.P.Present
Independent Consultant Xtripe AngelsPresent
Life Sciences Summer Associate Flagship PioneeringPresent
Independent Consultant University of Washington Applied Physics LaboratoryPresent
Co-Founder and CEO | Board of Directors Knome Inc.Present
Chief Strategy Officer | Chief Financial Officer | Chief Product Officer Syros PharmaceuticalsPresent
Board Member Tmunity Therapeutics IncorporatedPresent
Board Member Aria PharmaceuticalsPresent
Board Member EQRxPresent
Board Member CAMP4 TherapeuticsPresent
Board Member Tome BiosciencesPresent
Board Member IDRxPresent
Independent Consultant Self-EmployedPresent
Board Member EarliPresent
Board Member OctantPresent
Board Member Komodo HealthPresent
Board Member Vicinitas TherapeuticsPresent
Board Member Cartography BiosciencesPresent
Independent Consultant NewCoPresent
Board Member Earli Inc.Present
Board Member AsimovPresent
Board Member Dyno TherapeuticsPresent
General Partner Andreessen HorowitzPresent
Chief Strategy Officer Syros PharmaceuticalsPresent
Marketing & Operations Manager MedImmunePresent
Independent Consultant Biotechnology and genomics companiesPresent
Life Sciences Summer Associate Flagship VenturesPresent
Biotechnology Investment Banking Morgan StanleyPresent

Jorge Conde's Education

Harvard Business School Master of Business Administration (MBA)
The Johns Hopkins University Bachelor of Arts (BA) Biology
Massachusetts Institute of Technology Master of Science (MS) Biomedical Enterprise Program
Harvard-MIT Division of Health Sciences and Technology (HST) Master of Science (MS) Biomedical Enterprise Program